arrow
D

Darren K. McGuire

parkland health & hospital system
H指数:116
被引数:10.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PharmaPlain: SOUL trial looking at the effect of oral semaglutide on cardiovascular outcomes in people with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease

PharmaPlain:SOUL试验评估口服司美格鲁肽对伴有2型糖尿病和动脉粥样硬化性心血管疾病和/或慢性肾脏疾病患者心血管结局的影响

2026-08-260
OAAI
Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis

司美格鲁肽对SELECT、FLOW和SOUL试验中肾脏结局的影响:一项预先指定的合并分析

2026-08-070
PRE
Outcomes in patients with diabetes, atherosclerotic cardiovascular disease, and heart failure treated with tirzepatide or dulaglutide: SURPASS-CVOT analysis

糖尿病、动脉粥样硬化性心血管疾病和心力衰竭患者接受替尔泊肽或杜拉格鲁肽治疗的结果:SURPASS-CVOT分析

2026-01-010
OA
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes

在2型糖尿病中,替西帕肽与度拉糖肽的心血管结局比较

2025-12-1812
PRE
Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MI

dapagliflozin治疗后射血分数不同的心肌梗死患者的心血管代谢结局:DAPA-MI

2025-09-010
OAAI
Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-Diabetes trial

美国心脏病诊所开具SGLT-2i和/或GLP-1RA处方的患者特征:来自COORDINATE-Diabetes试验的见解

2025-07-230
OAAI
Incretin-based therapies for individuals with obesity and heart failure with mildly reduced or preserved ejection fraction: A systematic review and meta-analysis of randomized controlled trials

基于肠促胰岛素的治疗方法用于肥胖合并轻度降低或保留射血分数的心力衰竭患者:一项随机对照试验的系统评价和荟萃分析

2025-06-110
PRE
Advancement of the implementation of evidence-based therapies for cardiovascular-kidney-metabolic conditions: A multi-stakeholder perspective

心血管-肾脏-代谢疾病循证疗法的实施进展:多利益相关方视角

2025-05-070
PRE
Di scontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics

在美国心脏病诊所治疗的2型糖尿病和动脉粥样硬化性心血管疾病患者中继续SGLT-2i和GLP-1RA

2025-04-010
PRE
Cardiometabolic risk factors and disease trends for atrial fibrillation in individuals with type 1 diabetes: a nationwide registry study

心房颤动的心血管代谢危险因素和疾病趋势:1型糖尿病人群的全国登记研究

2025-03-120
OA
Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without Type 2 Diabetes and/or Overweight or Obesity

比较胰高血糖素样肽1受体激动剂在亚洲与白种人群中心血管结局的疗效:系统评价和随机试验的Meta分析(研究对象为有或无2型糖尿病和/或超重或肥胖的人群)

2025-02-200
OA